Background The results from small clinical studies suggest that therapy with adult bone
marrow (BM)–derived cells (BMCs) reduces infarct size and improves left ventricular function …

Rationale: Notwithstanding the uncertainties about the outcomes of bone marrow cell (BMC)
therapy for heart repair, further insights are critically needed to improve this promising …

Background—Despite rapid clinical translation and widespread enthusiasm, the therapeutic
benefits of adult bone marrow cell (BMC) transplantation in patients with ischemic heart …

Background Pilot trials suggest that the intracoronary administration of autologous
progenitor cells may improve left ventricular function after acute myocardial infarction …

OBJECTIVE: To review the milestones in stem cell therapy for ischemic heart disease from
early basic science to large clinical studies and new therapeutic approaches. MATERIALS …

Objectives: The aim of this study was to identify an association between the quality and
functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular …

Intracoronary transplantation of peripheral blood-or bone marrow-derived cells, as tested in
several recent trials, is associated with moderate increases in left ventricular (LV) ejection …

Background Experimental and clinical studies have suggested that intracoronary infusion of
bone marrow-derived stem/progenitor cells (BMC) may improve left ventricular function after …

Aims To investigate whether there are important sources of heterogeneity between the
findings of different clinical trials which administer autologous stem cell treatment for acute …

Background—The aim of this study was to investigate the clinical outcome 2 years after
intracoronary administration of autologous progenitor cells in patients with acute myocardial …